These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29672839)

  • 21. Prostacyclin-synthase expression in head and neck carcinoma patients and its prognostic value in the response to radiotherapy.
    Camacho M; Piñeiro Z; Alcolea S; García J; Balart J; Terra X; Avilés-Jurado FX; Soler M; Quer M; León X; Vila L
    J Pathol; 2015 Jan; 235(1):125-35. PubMed ID: 25256272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of L-arginine in the vascular actions and development of tolerance to nitroglycerin.
    Abou-Mohamed G; Kaesemeyer WH; Caldwell RB; Caldwell RW
    Br J Pharmacol; 2000 May; 130(2):211-8. PubMed ID: 10807657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The nitric oxide donor RuBPY does not induce in vitro cross-tolerance with acetylcholine.
    Paulo M; Grando MD; da Silva RS; Minshall RD; Bendhack LM
    Nitric Oxide; 2017 Sep; 69():69-77. PubMed ID: 28559108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective inhibition of prostacyclin synthase activity by rofecoxib.
    Griffoni C; Spisni E; Strillacci A; Toni M; Bachschmid MM; Tomasi V
    J Cell Mol Med; 2007; 11(2):327-38. PubMed ID: 17488481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained Formation of Nitroglycerin-Derived Nitric Oxide by Aldehyde Dehydrogenase-2 in Vascular Smooth Muscle without Added Reductants: Implications for the Development of Nitrate Tolerance.
    Opelt M; Wölkart G; Eroglu E; Waldeck-Weiermair M; Malli R; Graier WF; Kollau A; Fassett JT; Schrammel A; Mayer B; Gorren ACF
    Mol Pharmacol; 2018 Apr; 93(4):335-343. PubMed ID: 29358221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study.
    Gori T; Burstein JM; Ahmed S; Miner SE; Al-Hesayen A; Kelly S; Parker JD
    Circulation; 2001 Sep; 104(10):1119-23. PubMed ID: 11535566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostacyclin in endotoxemia-induced acute kidney injury: cyclooxygenase inhibition and renal prostacyclin synthase transgenic mice.
    Wang W; Zolty E; Falk S; Summer S; Stearman R; Geraci M; Schrier R
    Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1131-6. PubMed ID: 17652370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic-deletion of Cyclooxygenase-2 Downstream Prostacyclin Synthase Suppresses Inflammatory Reactions but Facilitates Carcinogenesis, unlike Deletion of Microsomal Prostaglandin E Synthase-1.
    Sasaki Y; Kamiyama S; Kamiyama A; Matsumoto K; Akatsu M; Nakatani Y; Kuwata H; Ishikawa Y; Ishii T; Yokoyama C; Hara S
    Sci Rep; 2015 Nov; 5():17376. PubMed ID: 26611322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial Nitric Oxide Synthase-Derived Nitric Oxide Prevents Dihydrofolate Reductase Degradation via Promoting S-Nitrosylation.
    Cai Z; Lu Q; Ding Y; Wang Q; Xiao L; Song P; Zou MH
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2366-73. PubMed ID: 26381869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenoassociated virus-mediated prostacyclin synthase expression prevents pulmonary arterial hypertension in rats.
    Ito T; Okada T; Mimuro J; Miyashita H; Uchibori R; Urabe M; Mizukami H; Kume A; Takahashi M; Ikeda U; Sakata Y; Shimada K; Ozawa K
    Hypertension; 2007 Sep; 50(3):531-6. PubMed ID: 17635855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitroglycerin tolerance in caveolin-1 deficient mice.
    Mao M; Varadarajan S; Fukai T; Bakhshi FR; Chernaya O; Dudley SC; Minshall RD; Bonini MG
    PLoS One; 2014; 9(8):e104101. PubMed ID: 25158065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complex I dysfunction and tolerance to nitroglycerin: an approach based on mitochondrial-targeted antioxidants.
    Esplugues JV; Rocha M; Nuñez C; Bosca I; Ibiza S; Herance JR; Ortega A; Serrador JM; D'Ocon P; Victor VM
    Circ Res; 2006 Nov; 99(10):1067-75. PubMed ID: 17053193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of heme environment and mechanism of peroxide bond cleavage in human prostacyclin synthase.
    Yeh HC; Hsu PY; Wang JS; Tsai AL; Wang LH
    Biochim Biophys Acta; 2005 Dec; 1738(1-3):121-32. PubMed ID: 16406803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of lipoic acid in prevention of nitroglycerin tolerance.
    Dudek M; Bednarski M; Bilska A; Iciek M; Sokołowska-Jezewicz M; Filipek B; Włodek L
    Eur J Pharmacol; 2008 Sep; 591(1-3):203-10. PubMed ID: 18616939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial nitric oxide synthase-dependent tyrosine nitration of prostacyclin synthase in diabetes in vivo.
    Nie H; Wu JL; Zhang M; Xu J; Zou MH
    Diabetes; 2006 Nov; 55(11):3133-41. PubMed ID: 17065353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of prostacyclin/PGI2 synthase expression after cerebral ischemia-reperfusion.
    Fang YC; Wu JS; Chen JJ; Cheung WM; Tseng PH; Tam KB; Shyue SK; Chen JJ; Lin TN
    J Cereb Blood Flow Metab; 2006 Apr; 26(4):491-501. PubMed ID: 16094316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial oxidative stress and nitrate tolerance--comparison of nitroglycerin and pentaerithrityl tetranitrate in Mn-SOD+/- mice.
    Mollnau H; Wenzel P; Oelze M; Treiber N; Pautz A; Schulz E; Schuhmacher S; Reifenberg K; Stalleicken D; Scharffetter-Kochanek K; Kleinert H; Münzel T; Daiber A
    BMC Cardiovasc Disord; 2006 Nov; 6():44. PubMed ID: 17092343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular histones disarrange vasoactive mediators release through a COX-NOS interaction in human endothelial cells.
    Pérez-Cremades D; Bueno-Betí C; García-Giménez JL; Ibañez-Cabellos JS; Hermenegildo C; Pallardó FV; Novella S
    J Cell Mol Med; 2017 Aug; 21(8):1584-1592. PubMed ID: 28244682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of in vivo nitrate tolerance on hypersensitivity to NO donors after NO-synthase blockade.
    Ratz JD; Adams MA; Bennett BM
    Can J Physiol Pharmacol; 2002 Nov; 80(11):1106-18. PubMed ID: 12489930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organic mononitrites of 1,2-propanediol act as an effective NO-releasing vasodilator in pulmonary hypertension and exhibit no cross-tolerance with nitroglycerin in anesthetized pigs.
    Nilsson KF; Goździk W; Frostell C; Zieliński S; Zielińska M; Ratajczak K; Skrzypczak P; Rodziewicz S; Albert J; Gustafsson LE
    Drug Des Devel Ther; 2018; 12():685-694. PubMed ID: 29636602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.